To sum up, although dexmedetomidine can lead to tau hyperphosphorylation and aggregation, the interaction of various kinases of tau protein phosphorylation remains unknown, and dexmedetomidine does not cause cognitive impairment based on the literature on the use of dexmedetomidine which reported a low incidence of negative cognitive function. This evidence concerns the gene MAPT and Cognitive impairment.